Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Microsemi CRP Automated Hematology Analyzer Evaluated

By LabMedica International staff writers
Posted on 05 Feb 2015
Complete blood counts (CBC) including white blood cell count (WBC) differentials and C-reactive protein (CRP) have been frequently utilized as the biomarkers for inflammatory diseases such as bacterial infection.

An automated hematology analyzer has been developed which can simultaneously measure CBC including three-part WBC differential (3-Diff) and CRP using ethylenediaminetetraacetic acid dipotassium salt dihydrate (EDTA-2K) anticoagulated whole blood without centrifugation for serum preparation.

Scientists at HORIBA Medical (Kyoto, Japan) used the company’s automated hematology analyzer, The Microsemi CRP, which is equipped with the electrical resistance method for CBC with 3-Diff of granulocytes (GRA) including neutrophils eosinophils and basophils, lymphocytes (LYM), and monocytes (MON). CRP is measured with the latex immune turbidimetry method following the prompt hemolyzation of EDTA-2K anticoagulated whole blood. The obtained value is then converted into plasma concentration according to hematocrit (HCT %) of respective sample to finally provide as ‘whole blood CRP.’

Correlation tests for the Microsemi CRP were compared with those of Micros CRP200, a preceding Horiba Medical model, and also those of the ADVIA 2120i (Siemens; Munich, Germany) routine hematology analyzer. The results of fresh whole blood and serum CRP obtained using Micros CRP200 were compared with those of serum CRP obtained using HITACHI 7600 routine analyzer (Tokyo, Japan).

The CBC data examined using Microsemi CRP showed excellent correlation with the previous model, Micros CRP200and also those obtained using the routine analyzer, ADVIA 2120i. In regards to the 3-Diff, both GRA (%) and LYM (%) showed the excellent correlation coefficient between Microsemi CRP and Micros CRP200 as well as ADVIA 2120i. (MON (%) showed good correlation between Microsemi CRP and Micros CRP200, but lower correlation between Microsemi CRP and ADVIA 2120. CRP data showed the good correlation with HITACHI 7600 and Micros CRP200.

The authors concluded that Microsemi CRP was a convenient laboratory analyzer which could provide the clinically reliable data about CBC including 3-Diff and CRP using only 18 μL whole blood within approximately four minutes. Therefore, Microsemi CRP seemed suitable in the setting of point of care testing (POCT) for the patients with inflammatory diseases such as bacterial infection, especially for pediatric ones in whom sufficient volume of samples necessary to simultaneous measurement of CBC including WBC Diff and CRP using the routine analyzers. The study was first published online on December 11, 2014, in the International Journal of Laboratory Hematology.

Related Links:

HORIBA Medical
Siemens
HITACHI 



Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Toxoplasma Gondii Immunoassay
Toxo IgM AccuBind ELISA Kit
New
Troponin I Test
Quidel Triage Troponin I Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The ready-to-use DUB enzyme assay kits accelerate routine DUB activity assays without compromising data quality (Photo courtesy of Adobe Stock)

Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation

Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.